AlphaCore Pharma LLC Report issue

For profit Phase 1
Founded: Ann Arbor MI United States (2007)
Status: Acquired by AstraZeneca (2013)

Organization Overview

First Clinical Trial
2012
NCT01554800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alphacore Pharma, LLC

Active Ingredients

Drugs in Phase 1 Trials (1)

acp-501 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 1)

Coronary Artery Disease (Phase 1)

Coronary Disease (Phase 1)

Myocardial Ischemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1